In my two decades of clinical practice—whether I am consulting with families in the Philippines or working with the vibrant retirement community in Alicante, Spain—I have often discussed the search for an Alzheimer’s cure as a race against time. For years, the traditional “drug discovery” model has been agonizingly slow. We are used to a cycle that takes 10 to 15 years and billions of pounds to bring a single molecule from the lab to the pharmacy shelf, often with no guarantee of success.
However, as we move through March 2026, a groundbreaking study from the University of Exeter, funded by the Alzheimer’s Society, has illuminated a much faster, safer, and more affordable path: Drug Repurposing. Instead of starting from scratch, an international panel of 21 dementia specialists evaluated 80 existing medications to see if any could take on a second, heroic life in the fight against dementia.
The results, published in Alzheimer’s Research and Therapy, have spotlighted three familiar medicines as the most promising candidates for protecting the aging brain: a shingles vaccine, Viagra (sildenafil), and a motor neurone disease drug called riluzole. This discovery represents a shift toward what I call the “Medicine of Opportunity”—using what we already know is safe to solve our most devastating health crisis.
1. The Revolution of Drug Repurposing: Faster, Safer, Smarter
Repurposing is not a new concept in medicine. Years ago, we saw aspirin transition from a simple painkiller to a staple for reducing the risk of heart attack or stroke. In the field of dementia, where one in three people born today will develop the condition, we simply cannot afford to wait for the standard 15-year development cycle.
The Delphi Consensus: 21 Experts, One Goal
To reach these conclusions, researchers used a “Delphi consensus” method. This involved an international group of specialists from universities, hospitals, and the pharmaceutical industry, along with people directly affected by dementia. They reviewed 80 existing medications, filtering them through multiple rounds of review based on three criteria:
- Biological Plausibility: Does the drug target biological processes known to be linked to Alzheimer’s?
- Experimental Evidence: Has the drug shown encouraging results in cell and animal studies?
- Clinical Safety: Is the drug proven to be safe for long-term use in older adults?
The “Priority Three” Candidates
After exhaustive analysis, the panel agreed on three “priority candidates.” These drugs aren’t just guesses; they are existing tools that have already been vetted for other conditions, meaning they could be ready for widespread Alzheimer’s use much sooner than a brand-new chemical entity.
2. The Shingles Signal: Why an Immune Boost May Block Dementia
Among the 80 drugs reviewed, the shingles vaccine (Zostavax) emerged as the undisputed front-runner. In my practice, I often describe the immune system as the “Janitorial Crew” of the brain. When it functions well, it clears metabolic debris; when it falters, chronic inflammation takes over, leading to what we call “neuro-metabolic weathering.”
The 16% Risk Reduction
The Exeter panel noted that previous research had already identified a powerful signal: individuals who received the shingles vaccine were approximately 16% less likely to develop dementia.
The possible mechanisms behind this are fascinating:
- The Viral Trigger: There is mounting evidence that the shingles virus (varicella-zoster) may play a role in triggering the neuro-inflammation that characterizes Alzheimer’s disease.
- Immune Priming: The vaccine interacts with the immune system in a way that may “prime” it to counter harmful changes in the brain before they become irreversible.
- Minimal Intervention, Maximum Safety: Because the vaccine requires only one or two doses and has a long, established record of safety, it is arguably the most accessible tool in our new “Brain Shield.”
The PROTECT Registry and Future Trials
Researchers are now pushing for large-scale clinical trials in the UK. Many of these will leverage the PROTECT online registry, where volunteers take part in brain health research annually. This will allow scientists to track exactly how these immune signals translate into long-term cognitive stability.
3. The Sildenafil Strategy: Increasing Blood Flow and Reducing Tau
The second candidate, sildenafil (well-known as Viagra), is perhaps the most surprising to the general public. However, from a vascular health perspective, its inclusion is entirely logical. In my work with CKM Syndrome (Cardiovascular-Kidney-Metabolic link), I look at blood flow as the “Lifeblood of Cognition.”
Beyond Erectile Dysfunction: A Neuro-Protective Molecule
Research indicates that sildenafil may protect the brain through two distinct, powerful pathways:
- Vascular Dilation: By increasing blood flow to the brain (cerebral perfusion), sildenafil ensures that neurons receive the oxygen and nutrients they need while efficiently flushing out metabolic waste.
- The Tau Combatant: In mouse studies, sildenafil has shown the ability to reduce the buildup of tau, a toxic protein that accumulates abnormally and forms “tangles” that kill brain cells.
Improving Thought and Memory
In animal models, sildenafil didn’t just halt the progression of decline; it actually improved thinking and memory. This suggests that by supporting the “plumbing” of the brain, we can directly protect and even enhance the “wiring.”
4. Riluzole: Repurposing a Defense Against Motor Neurone Disease
The third priority candidate is riluzole, a medication currently prescribed for Motor Neurone Disease (MND). While MND and Alzheimer’s are different conditions, they share a common enemy: the accumulation of toxic proteins and the breakdown of communication between nerve cells.
Lowering the Toxic Load
In animal studies, riluzole has demonstrated a remarkable ability to:
- Target Tau Levels: It helps lower the levels of the tau protein that would otherwise lead to neurofibrillary tangles.
- Sustain Cognitive Performance: It appears to support the brain’s ability to maintain cognitive function even when under the stress of neurodegenerative changes.
| Priority Candidate | Primary Use | Proposed Alzheimer’s Mechanism |
| Shingles Vaccine | Infection Prevention | Counters harmful immune system changes |
| Sildenafil (Viagra) | Erectile Dysfunction | Increases blood flow & reduces tau protein |
| Riluzole | Motor Neurone Disease | Lowers tau levels & improves cell communication |
5. The Systems View: How This Fits into Your 2026 Longevity Roadmap
As a health thought partner, I view these repurposed drugs not as “magic pills,” but as tools that must be integrated into a larger Systemic Resilience strategy. We are moving toward a model of “Multi-Modal Prevention”.
Synergy with the “Newcastle Burst”
We know from the Newcastle University study that just 10 minutes of intense exercise triggers DNA repair genes like PNKP. Imagine the combined effect of an immune-priming vaccine, a vascular-boosting molecule like sildenafil, and the genetic “reset” of a brief workout. These are not separate ideas; they are synergistic pieces of the same puzzle.
The CKM and Environmental Shield
As seen in the Emory University study, air pollution (PM2.5) is a direct risk factor for Alzheimer’s.
- The Defense: If sildenafil improves cerebral blood flow, it may help the brain more efficiently “flush” the environmental toxins and particulate matter that would otherwise trigger neuro-inflammation.
- The Foundation: Optimal Vitamin D levels (>40 ng/mL) and vascular integrity remain the bedrock upon which these repurposed drugs will perform their best work.
6. Dr. Marie’s Clinical Perspective: Intellectual Honesty and Hope
While these findings are exciting, it is vital to practice Intellectual Honesty. Dr. Anne Corbett from the University of Exeter reminds us that robust clinical trials are still needed before these can be officially recommended, specifically for Alzheimer’s treatment or prevention.
“Drug repurposing is a vital part of that mix, helping us turn today’s medicine for one condition, into tomorrow’s treatment for another.” — Dr. Anne Corbett
My Recommendations for 2026:
- Stay Current on Vaccines: If you are over 50 or eligible for the shingles vaccine, get it. Not only does it prevent a painful condition, but the potential 16% reduction in dementia risk is a significant “longevity bonus.”
- Prioritize Vascular Health: Sildenafil’s potential highlights how critical blood flow is. Manage your blood pressure and sugar now to protect the vessels that will feed your brain in 20 years.
- The 10-Minute Rule: Continue the Newcastle Burst workouts. They provide the cellular energy and DNA repair mechanisms that allow any future medication to work more effectively.
How I Can Help You Navigate the Frontier of Brain Health
At Puente Costa Blanca, we don’t just follow traditional protocols; we interpret the latest 2026 research to build your personalized Precision Longevity plan.
Online Medical Consultations (Philippines & Global)
For my global community, I offer secure, 24/7 consultations via SeriousMD.
- Vascular Integrity Audit: Reviewing your blood flow markers to see if you are a candidate for vascular-supporting protocols.
- Immune Resilience Review: Discussing the role of vaccines and anti-inflammatory strategies in your specific “Brain Shield.”
- Repurposing Consultation: A deep dive into your current medications to see if any have “hidden” neuro-protective benefits.
BOOK YOUR MEDICAL CONSULTATION NOW ON SERIOUSMD
Geriatric Rehab & Anti-Aging Clinic (Alicante & Costa Blanca, Spain)
For the international community in Spain, we specialize in the “Integrated Neuro-Physical Training” required for long-term functional autonomy.
Visit our local sites: Puente Costa Blanca (.com) |Puente Costa Blanca (.es)
Our Specialized Services in Spain:
- Neuro-Functional Training: Specific brain-body drills (like the Johns Hopkins SOP training) combined with metabolic optimization.
- Sarcopenia & Vitality: Building the physical strength that supports the cardiovascular health necessary for a “high-speed” brain.
- Autonomy & Comfort: Managing the chronic neuro-inflammation associated with aging to keep your mind clear and your spirit vibrant.
Final Thoughts from Dr. Marie
The idea that tomorrow’s Alzheimer’s treatment might already be sitting in your medicine cabinet for shingles or MND is a profound testament to Systemic Resilience. We are learning that the body’s systems are deeply interconnected—and by treating one, we often protect them all.
By staying informed and proactive, you are flipping your genetic switches toward a future of clarity and independence.
Dr. Marie Gabrielle A. Laguna, MSc, M.D., FPCP, FDip (Geriatric Rehab, UK) Internal Medicine & Senior Health Specialist



